The global pharmaceuticals behemoth is planning to reduce emissions by 40 per cent by 2025, CEO Christophe Weber announced yesterday
Japanese pharmaceutical giant Takeda will strive to achieve carbon neutrality across its value chain by 2040, the firm announced yesterday, as part of a raft of environmental, social and governance (ESG)...
To continue reading this article...
Join BusinessGreen
- Enjoy exclusive news, insights and analysis from Europe’s leading source of information on the green economy and business.
- Make smart, responsible business decisions with an eye on the latest regulatory and tech developments
- Stay in the know with our overnight briefing, expertly curated help you run a competitive and sustainable business
- Tap into our extensive archive of exclusive articles, news, analysis and guides
- Access our Intelligence Reports and exclusive data-rich studies on business-critical aspects of the green economy (BG Advanced members only)
- Choose from 3 paid membership levels or start a 7-day no strings trial
